Clinical Trials
2 trialsNCT01835223 2020-10-28
Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT02409524 2020-01-22
An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects
Mirror Biologics, Inc.
Phase 2 Completed